United States: Staph Infections In The Workplace

Last Updated: October 30 2007
Article by Donald W. Benson

Recent news reports detail super-drug-resistant staph infections in schools across the country and school closings for the cleaning of shared surfaces, particularly with respect to shower areas and shared sports equipment.1 Employers should prepare for anticipated questions from employees about rumors of such super-staph infections among coworkers, contamination risks in the workplace, and precautions that the employer is implementing to maintain a safe work environment.

What is MRSA Staph Infection?

Staphylococcus aureus (staph) are bacteria that are commonly found on the skin or in the nose of healthy people. Approximately 25% to 30% of the population are "colonized" (i.e. bacteria are present without causing infection) in the nose with such staph bacteria. Although staph bacteria are some of the most common causes of skin infections in the United States (such as pimples and boils), staph bacteria can also cause serious infections including surgical wound infections, bloodstream infections and pneumonia.2

Some staph infections are resistant to some antibiotics. MRSA (methicillin-resistant Staphylococcus aureus) is a staph that is resistant to beta-lactam antibiotics, which include common antibiotics such as oxacillin, penicillin and amoxicillin. While 25% to 30% of the population may be colonized with staph bacteria, only about 1% are colonized with MRSA.

An article in the October 17, 2007 issue of the Journal of the American Medical Association3 adopted a different method of counting cases and reported a significantly higher number of deaths (94,360) in 2005 due to MRSA infection. According to the article, approximately 18,650 persons died during a hospital stay related to such serious MRSA infections. Serious MRSA disease is still predominantly related to exposures in the healthcare industry. About 85% of all invasive MRSA infections were associated with healthcare. Of that 85%, two-thirds occurred outside of the hospital setting in nursing home or extended care facilities. Only about 14% of over-all cases were infections occurring in persons without an obvious exposure to healthcare services.

How is it Spread?

The Centers for Disease Control and Prevention ("CDC") has investigated clusters of CA-MRSA skin infections among athletes, military recruits, children, Pacific Islanders, Alaskan Natives, native Americans, men who have sex with men, and prisoners. Factors associated with the spread of MRSA skin infections include: close skin-to-skin contact, openings in the skin like cuts or abrasions, contaminated items and surfaces, crowded living conditions and poor hygiene.


Prevention of staph or MRSA skin infections includes good hygiene practices:

  1. Clean hands regularly with soap and water or using alcohol-based hand sanitizer.
  2. Keep cuts and scrapes clean and covered with dry bandages.
  3. Avoid contact with other people's bandages or wounds.
  4. Avoid sharing personal items like razors or towels.

People with weakened immune systems, including those with HIV infection, may be at risk for more severe illness if they get infected, but the CDC at this point recommends only that such persons exercise the same good hygiene practices.4

Employers need to consider how to educate employees and visitors on such "good hygiene" practices and whether "health monitors" or disciplinary actions might be appropriate as part of the program. Additional steps might include: increased cleaning of commonly shared work spaces, ensuring the availability of soaps and alcohol wipes, proper disposal of wipes, towels and bandages, personal protective equipment for first aid providers, sick bay precautions and protocols, and communication plans to inform employees of possible infections and precautions without raising privacy issues or promoting panic.


Staph infections and MRSA infections are treatable. For many staph infections, treatment may not even include antibiotics but may be accomplished by a healthcare provider draining the abscess or boil and dressing the wound with a dry bandage. MRSA infections are treatable with some antibiotics. Patients should take all of the doses of prescribed antibiotics and not share or save unfinished antibiotics for use at another time.

Employer Responses

At this stage of OSHA public information5 and CDC guidelines, employers would be well advised to beware of the general duty clause of the OSH Act,6 which imposes on employers a duty to avoid certain recognized hazards in the workplace, and other potentially relevant OSHA requirements, like an employer's bloodborne pathogens program.7

An employer faced with an employee who self-discloses that he or she has an MRSA infection needs to be mindful of several potential legal pitfalls. The employee may well be entitled to the protections of the Americans with Disabilities Act, including protection from retaliation and reasonable accommodation, which might entail time and a location to change bandages or leave from work to obtain on-going treatment. Employees may be entitled to FMLA leave or other company-provided leave to care for themselves or an infected family member. Furthermore, such shared confidential medical information also raises privacy concerns and potential HIPAA obligations, particularly as an employer takes steps to disinfect and clean the workplace or takes other contamination precautions.

MRSA infections also raise a relatively new problem for employers similar to the challenges of preparations for avian flu, SARS, drug-resistant tuberculosis, and other pandemic illnesses. Each of these highly-contagious health threats creates new demands on employers to prepare emergency health plans involving all facets of their operations. Such emergency planning might include examining how normal operations and the worksite could be changed to minimize face-to-face interactions of employees and promote social distancing (greater than three feet) in times of a pandemic flu epidemic, securing and training employees on the use and disposal of personal protective equipment including masks and gloves, monitoring employees' use of good hygiene practices in the workplace, such as skin-to-skin contact and cough etiquette, arranging for the proper disposal of tissues and bandages, increased cleaning of shared work spaces and gathering locations, helping employees not to infect each other or the public, maintaining IT and financial data processing during employee absences, and shifting operations to non-infected areas. Employers need to plan for significant worker shortages as employees may be too sick to work, absent to provide care to others, or too scared to come to work. The challenge is not only to maintain operations during high absenteeism, but to plan for an orderly and prompt period of recovery. Employment concerns raised by these highly contagious illnesses call for a level of sophistication about health issues, proactive emergency planning, and employee communication protocols that extend far beyond the issues raised by how to respond to a single sick employee.


1. See "Staph Infections Reported At Schools Across The Country," The New York Times, Oct. 17, 2007, available at http://nytimes.com/2007/10/17/us/17school-cnd.html; Guest Column: Finding the facts on student infections, Frances B. Phillips, Maryland Gazette, Oct. 17, 2007 (commenting on two weeks of reports about skin infections primarily affecting county high school students).

2. "Community-Associated MRSA Information for the Public" at http://www.cdc.gov/ncidod/dhqp/ar_mrsa_ca_public.html.

3. Journal of the American Medical Association, 2007; 298(15):1763-1771.

4. CDC recommendations for patient care related to prevention and management of the transmission of MRSA in hospitals may be found at Management of Multidrug Resistant Organisms In Healthcare Settings, 2006, available at CDC "Infection Control guidelines" at http://www.cdc.gov/ncidod/dhqp/guidelines.html.

5. OSHA at this stage has merely issued public information on its website paraphrasing the CDC information and recommendations. "Hospital eTool-HealthCare Wide Hazards Module: MRO-Multi-Resistant organisms," at http://www.osha.gov/SLTC/etools/hospital/hazards/mro/mro.html.

6. Each employer "shall furnish to each of his employees employment and a place of employment which are free from recognized hazards that are causing or are likely to cause death or serious harm to his employees." 29 U.S.C. § 654.

7. The Bloodborne Pathogens Standard requires precautions when dealing with blood and other potentially infectious materials. 29 CFR §§1910.1030, et seq.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

In association with
Related Topics
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Mondaq Free Registration
Gain access to Mondaq global archive of over 375,000 articles covering 200 countries with a personalised News Alert and automatic login on this device.
Mondaq News Alert (some suggested topics and region)
Select Topics
Registration (please scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions